Kouiavskaia Diana V, Southwood Scott, Berard Carla A, Klyushnenkova Elena N, Alexander Richard B
Division of Urology, Department of Surgery, University of Maryland School of Medicine and Urology Section, Veterans Affairs Maryland Health Care System, Baltimore, Maryland 21201, USA.
J Urol. 2009 Nov;182(5):2483-9. doi: 10.1016/j.juro.2009.07.067. Epub 2009 Sep 17.
A potential etiology of chronic prostatitis/chronic pelvic pain syndrome is autoimmunity. We determined whether T cells from men with chronic prostatitis/chronic pelvic pain syndrome would recognize peptides derived from the normal self-prostatic proteins prostate specific antigen and prostatic acid phosphatase.
CD4 T cells purified from peripheral blood of 31 patients with chronic prostatitis/chronic pelvic pain syndrome and from the buffy coat preparation of 27 normal male blood donors were stimulated in vitro with a panel of immunogenic peptides from prostate specific antigen and prostatic acid phosphatase, and assayed for reactivity with the peptides by interferon-gamma enzyme-linked immunosorbent spot assay. Intermediate resolution HLA typing was done by polymerase chain reaction. Peptides were also tested by binding assay against different class II alleles.
Peptide PAP(173-192) was recognized more frequently by CD4 T cells from patients with chronic prostatitis/chronic pelvic pain syndrome than from healthy donors. The recognition of prostate specific antigen peptides was not statistically different when comparing cases to normal male blood donors individually. Peptide reactivity was more common in patients than in normal male blood donors for any prostate specific antigen peptide or any tested peptide. All peptides showed high promiscuity on binding assays. There was no association of cases with any specific HLA class II phenotype at intermediate resolution.
CD4 T cells from patients with chronic prostatitis/chronic pelvic pain syndrome have a higher rate of recognizing the self-prostatic proteins prostatic acid phosphatase and prostate specific antigen compared to those from normal male blood donors. Data provide further evidence to support the role of autoimmunity in some men with chronic prostatitis/chronic pelvic pain syndrome.
慢性前列腺炎/慢性盆腔疼痛综合征的一种潜在病因是自身免疫。我们确定了慢性前列腺炎/慢性盆腔疼痛综合征男性患者的T细胞是否会识别源自正常自身前列腺蛋白前列腺特异性抗原和前列腺酸性磷酸酶的肽段。
从31例慢性前列腺炎/慢性盆腔疼痛综合征患者的外周血以及27名正常男性献血者的血沉棕黄层制备物中纯化出CD4 T细胞,在体外使用一组来自前列腺特异性抗原和前列腺酸性磷酸酶的免疫原性肽段进行刺激,并通过干扰素-γ酶联免疫斑点试验检测其与这些肽段的反应性。通过聚合酶链反应进行中等分辨率的HLA分型。还通过结合试验检测肽段与不同II类等位基因的结合情况。
与健康供者相比,慢性前列腺炎/慢性盆腔疼痛综合征患者的CD4 T细胞更频繁地识别肽段PAP(173 - 192)。将病例与正常男性献血者单独比较时,前列腺特异性抗原肽段的识别在统计学上无差异。对于任何前列腺特异性抗原肽段或任何测试肽段,患者中的肽段反应性比正常男性献血者更常见。所有肽段在结合试验中均表现出高度多态性。在中等分辨率下,病例与任何特定的HLA II类表型均无关联。
与正常男性献血者相比,慢性前列腺炎/慢性盆腔疼痛综合征患者的CD4 T细胞识别自身前列腺蛋白前列腺酸性磷酸酶和前列腺特异性抗原的比率更高。数据提供了进一步的证据支持自身免疫在一些慢性前列腺炎/慢性盆腔疼痛综合征男性患者中的作用。